Blog

  • Scenesse for EPP is ready for Prime Time

    Scenesse is a medicine that can give sufferers of Erythropoietic Protoporphyria (EPP) a new lease on life. The FDA approval of Scenesse for EPP in October 2019 was a watershed moment for US patients with this devastating disease. It has been a long time coming and it is now ready for use. The path to insurance approval is long and arduous but doable. Because it was just approved by the FDA, it will require a lot of flips and twists to get it to the patients who need it.

    Read more

  • Intimacy and Hidradenitis Suppurativa

    Hidradenitis Suppurativa isolates its sufferers like no other disease. Never knowing when an abscess will break or when a weeping sore under the arm will drip past the bandage and stain your clothes. It also often eliminates the ability to be intimate with your partner. You may also have experienced trauma related to multiple procedures and of course, grief and loss issues related to how deeply your life has changed because of HS.

    Read more

  • Skinifinity with Platelet-rich Plasma and Tranexamic Acid are the newest weapons in the fight against Melasma

    Skinifinity with Platelet-rich Plasma and Tranexamic Acid are the newest weapons in the fight against Melasma

    Read more

Love this Post? Spread the World

 

Contact us

2630 NE 203rd Street
Suite 105
Aventura, FL 33180

Tel :  
Fax : (305) 692–8606